ADDF organizes two major international scientific conferences yearly as part of our ongoing efforts to increase researchers’ knowledge about Alzheimer’s disease and the drug discovery process. The conferences promote networking to catalyze the exchange of ideas and foster alliances that accelerate the development of new treatments for AD.
Our Annual International Conference for Alzheimer’s Disease Drug Discovery, held in October, focuses on the discovery and development of drugs targeting Alzheimer’s disease and related dementias. The Drug Discovery for Neurodegeneration conference, held in February, is designed to educate scientists on the process of translating basic neuroscience research into innovative therapies. ADDF also plans smaller “catalyst conferences” that center on a relevant topic in the field of neurodegeneration.
We encourage individuals, foundations, and corporations to co-sponsor one of our semi-annual international conferences to advance Alzheimer’s drug discovery. For a minimum contribution of $7,500, conference co-sponsors are recognized in all conference-related materials, the post-conference journal, the ADDF Annual Report, and newsletter. Limited display space may be available, as is conference bag inclusion (at the discretion of the ADDF).
To discuss conference co-sponsorship, please contact Filomena Machleder, Assistant Director of Institutional Partnerships, at 212-901-8004 or fmachleder@alzdiscovery.org.